Phase 2 Colorectal Cancer Trial, Recruiting NCT06002789 Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 2 Colorectal Cancer Trial, Recruiting

NCT06002789
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with multiple separate colorectal cancers occurring at the same time, confirmed by a tissue sample (biopsy)
  • Lab tests on at least one of your tumors show a specific genetic feature called "mismatch repair deficiency" (dMMR) or "high microsatellite instability" (MSI-H), which affects how your cancer cells repair DNA
  • Your cancer is at a certain stage (T3 or T4, without distant spread), based on imaging scans — meaning the cancer has grown into or through the bowel wall but has not spread to distant parts of the body
  • You have had specific scans to stage your cancer, including CT scans of your chest, abdomen and pelvis, and a high-resolution MRI scan
  • You do not have a blocked bowel, or if you did, it has been relieved by a temporary bowel diversion surgery (colostomy)
  • You have never had surgery on your bowel or colon before
  • You have never had chemotherapy or radiotherapy before
  • You have never received biological therapies (such as certain antibody treatments) or immunotherapy drugs before
  • You have signed a form giving your informed consent to take part

Who may not be able to join:

  • You have a heart rhythm problem that needs certain medications to control it, significant heart disease, a heart attack within the last 6 months, or moderate-to-severe heart failure
  • You have high blood pressure that cannot be controlled with medication
  • You have HIV, or you currently have an active hepatitis B or C infection
  • You have active tuberculosis (TB), are currently being treated for TB, or were treated for TB within the past year
  • You currently have another serious active infection
  • Your cancer has spread to areas outside the pelvis (distant spread confirmed by scans)
  • You have serious problems with your blood or organ function
  • You have previously had radiotherapy to your pelvis or abdomen
  • You have epilepsy that requires ongoing treatment
  • You have been diagnosed with another type of cancer within the last 5 years
  • You have substance misuse issues, or mental health or social conditions that could affect your participation or the reliability of the study results
  • You have an active autoimmune disease (where your immune system attacks your own body) or a history of one — for example, certain lung, eye, gut, liver, kidney or thyroid conditions, or asthma requiring specific inhalers (confirm with trial site)
  • You have received any vaccine against an infection in the 4 weeks before joining the trial
  • You regularly take immune-suppressing medications or steroids above a certain dose
  • You are known to be allergic to any of the drugs used in this trial
  • You are in any unstable health condition that could put you at risk or affect your ability to take part safely
  • You are pregnant, breastfeeding, or able to have children but not using contraception
  • You do not wish to sign the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
1 May 2022
Est. completion
1 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

pCR rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov